95 related articles for article (PubMed ID: 2094579)
21. Immune response to Plasmodium berghei sporozoite antigens. I. Evaluation of murine T cell repertoire following immunization with irradiated sporozoites.
Krzych U
Am J Trop Med Hyg; 1991 Jun; 44(6):580. PubMed ID: 1858962
[No Abstract] [Full Text] [Related]
22. Cellular immune response to sheep erythrocytes: interrelationship between proliferation of popliteal lymph node cells and footpad swelling.
Papadimitriou C; Hahn H; Näher H; Kaufmann SH
Immunobiology; 1983 May; 164(5):361-9. PubMed ID: 6603413
[TBL] [Abstract][Full Text] [Related]
23. Establishment and comparison of delayed-type hypersensitivity models in the B₆C₃F₁ mouse.
Smith MJ; White KL
J Immunotoxicol; 2010; 7(4):308-17. PubMed ID: 20825253
[TBL] [Abstract][Full Text] [Related]
24. Acute malaria prolongs susceptibility of mice to Plasmodium berghei sporozoite infection.
Orjih AU
Clin Exp Immunol; 1985 Jul; 61(1):67-71. PubMed ID: 3899429
[TBL] [Abstract][Full Text] [Related]
25. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.
Mueller AK; Labaied M; Kappe SH; Matuschewski K
Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporin A prevents suppression of delayed-type hypersensitivity in mice immunized with high-dose sheep erythrocytes.
Webster LM; Thomson AW
Immunology; 1987 Mar; 60(3):409-14. PubMed ID: 3570356
[TBL] [Abstract][Full Text] [Related]
27. Immune response gene regulation of immunity to Plasmodium berghei sporozoites and circumsporozoite protein vaccines. Overcoming genetic restriction with whole organism and subunit vaccines.
Hoffman SL; Berzofsky JA; Isenbarger D; Zeltser E; Majarian WR; Gross M; Ballou WR
J Immunol; 1989 May; 142(10):3581-4. PubMed ID: 2497175
[TBL] [Abstract][Full Text] [Related]
28. A liver-stage specific antigen of P. berghei identified by a monoclonal antibody.
Winger L; Suhrbier A; O'Dowd CA; Hodivala KJ; Sinden RE
Bull World Health Organ; 1990; 68 Suppl(Suppl):172-7. PubMed ID: 2094583
[TBL] [Abstract][Full Text] [Related]
29. Suppression of an established DTH response to ovalbumin in mice by feeding antigen after immunization.
Lamont AG; Bruce MG; Watret KC; Ferguson A
Immunology; 1988 May; 64(1):135-9. PubMed ID: 3384449
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development.
Egan JE; Weber JL; Ballou WR; Hollingdale MR; Majarian WR; Gordon DM; Maloy WL; Hoffman SL; Wirtz RA; Schneider I
Science; 1987 Apr; 236(4800):453-6. PubMed ID: 3551073
[TBL] [Abstract][Full Text] [Related]
31. Arthus and delayed type of hypersensitivity to Pseudomonas aeruginosa antigens in mouse.
Maresz-Babczyszyn J; Kowalewska D; Sokalska M
Arch Immunol Ther Exp (Warsz); 1983; 31(2):217-30. PubMed ID: 6228203
[TBL] [Abstract][Full Text] [Related]
32. Apoptotic Plasmodium-infected hepatocytes provide antigens to liver dendritic cells.
Leiriao P; Mota MM; Rodriguez A
J Infect Dis; 2005 May; 191(10):1576-81. PubMed ID: 15838783
[TBL] [Abstract][Full Text] [Related]
33. Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria.
Rieckmann KH; Beaudoin RL; Cassells JS; Sell KW
Bull World Health Organ; 1979; 57 Suppl 1(Suppl):261-5. PubMed ID: 120773
[TBL] [Abstract][Full Text] [Related]
34. Duration of immunity following a single vaccination with irradiated sporozoites of Plasmodium berghei.
Pacheco ND; McConnell E; Beaudoin RL
Bull World Health Organ; 1979; 57 Suppl 1(Suppl):159-63. PubMed ID: 120765
[TBL] [Abstract][Full Text] [Related]
35. Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers.
Nardin EH; Nussenzweig RS; Altszuler R; Herrington D; Levine M; Murphy J; Davis J; Bathurst I; Barr P; Romero P
Bull World Health Organ; 1990; 68 Suppl(Suppl):85-7. PubMed ID: 2094595
[TBL] [Abstract][Full Text] [Related]
36. Co-localization of inducible-nitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites.
Klotz FW; Scheller LF; Seguin MC; Kumar N; Marletta MA; Green SJ; Azad AF
J Immunol; 1995 Apr; 154(7):3391-5. PubMed ID: 7534796
[TBL] [Abstract][Full Text] [Related]
37. Resolution of HSV corneal infection in the absence of delayed-type hypersensitivity.
Lausch RN; Kleinschradt WR; Monteiro C; Kayes SG; Oakes JE
Invest Ophthalmol Vis Sci; 1985 Nov; 26(11):1509-15. PubMed ID: 2997073
[TBL] [Abstract][Full Text] [Related]
38. Delayed hypersensitivity in mice infected with reovirus. I. Identification of host and viral gene products responsible for the immune response.
Weiner HL; Greene MI; Fields BN
J Immunol; 1980 Jul; 125(1):278-82. PubMed ID: 6247395
[TBL] [Abstract][Full Text] [Related]
39. Role of delayed type hypersensitivity responses in protection during chronic Plasmodium berghei infection as evidenced by homing of radiolabelled bone marrow cells and contact sensitivity.
Wangoo A; Ganguly NK; Mahajan RC
Jpn J Exp Med; 1990 Apr; 60(2):45-50. PubMed ID: 2200902
[TBL] [Abstract][Full Text] [Related]
40. H-2-dependent cell-mediated immunity in vivo: delayed-type hypersensitivity and contact sensitization induced by fluorescein isothiocyanate-conjugated cells.
Domoto DT; Askenase PW
J Immunol; 1980 Nov; 125(5):2161-6. PubMed ID: 7430623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
